An interventional study of new soft robotic glove in Stroke, sponsored by Chinese University of Hong Kong. Recruiting at 1 site in Hong Kong. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-01-09.
Sponsored by Chinese University of Hong Kong · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 54 studies in Stroke by Chinese University of Hong Kong — 20 open to participants now, 21 under way, none of them phase 3. Stroke · Chinese University of Hong Kong.
Among the 54 studies in Stroke by Chinese University of Hong Kong, this one is the 22nd largest by planned enrollment of the 41 interventional ones that give a count, is one of 2 that started in 2026, is one of 38 with no phase, reaches primary completion later than 15 of the 20 other live ones, and was the 51st registered.
8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.
Browse Stroke studies →20 of the 54 studies in Stroke by Chinese University of Hong Kong are open now, in 4 countries. Recruiting first, the newest first:
Chinese University of Hong Kong · Sites in China
Ages 18–80 · Healthy volunteers
Chinese University of Hong Kong · Sites in China
Ages 18+
Chinese University of Hong Kong · Sites in Hong Kong
Ages 65–80
Chinese University of Hong Kong · Sites in Hong Kong
Ages 18–80
Chinese University of Hong Kong · Sites in Hong Kong
Ages 18–100
By country, each count listing its studies:
Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.
This study: 18 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
54 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 3 · Phase 3 1
First in 2009; this study’s year is marked. 2 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 60 is above the median of 48 across 6,049 interventional studies indexed under Stroke.
Median enrollment 64 across the 41 interventional studies, 350 across the 13 observational. Of the 19 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Chinese University of Hong Kong is the lead sponsor of 1,458 studies on the registry; 478 are open to participants now.
Of its 6 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
4 of the studies in Stroke by Chinese University of Hong Kong that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06825598Chinese University of Hong KongNeuroarchitectural Recovery Model of Post-stroke Patients | 2026-12 |
| NCT06369051Chinese University of Hong KongSupporting Self-employment in Young Adults With Stroke | 2026-12-31 |
| NCT03291392Chinese University of Hong KongCUHK Stroke Biobank | 2026-12-31 |
| NCT05378035Chinese University of Hong KongDOAC in Chinese Patients With Atrial Fibrillation | 2027-09-27 |
Add all 4 to your calendar (.ics) → With an account.
Among the 54 studies in Stroke by Chinese University of Hong Kong, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this clinical trial is to investigate the feasibility of using the Soft Forearm Robot system for wrist and forearm recovery of hemiplegic subjects suffered from stroke.
Participant will attend 20 training sessions and 3 assessment sessions. This system will leverage electromyography (EMG) signals for intention detection and regulating the movement and the contact for different tasks and objects, ensuring adaptive and precise control for rehabilitation tasks. A systematic clinical study involving sixty stroke patients divided into three groups will evaluate the effectiveness of our innovative design compared to conventional rehabilitation methods. By conducting a randomized controlled trial (RCT), we aim to provide robust evidence on the benefits of our advanced robotic glove design in stroke rehabilitation. We hope our work will significantly advance the field of rehabilitation robotics by improving therapeutic practices, enhancing recovery outcomes, and elevating the quality of life for those facing hand mobility challenges. By integrating new soft robotic hand design with practical application, we aim to create an effective rehabilitation solution for everyone who needs it.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
which allows the pressure of the dual-chamber actuators to achieve full DOF for the thumb and fingers
Device: new soft robotic glove
providing only flexion and extension like most robotic systems in the clinical setting
Device: new soft robotic glove
Participants will follow their own regular rehabilitation program.
a soft robotic glove, with dual-chamber actuators
Fugl-Meyer Assessment for Upper Extremity (FMA-UE)
It is used to evaluate and measure upper-limb recovery in post-stroke hemiplegic patients, and items are scored on a 3-point ordinal scale
Time frame: 3-month after intervention
Action Research Arm Test (ARAT)
The ARAT is a 19-item measure divided into 4 sub-tests (grasp, grip, pinch, and gross arm movement) to assess upper limb functioning
Time frame: 3-month after intervention
Modified Ashworth Scale (MAS)
It measures the spasticity level of wrist, elbow and finger joint.
Time frame: 3-month after intervention
Box and Block Test (BBT)
Time frame: 3-month after intervention
Maximum Grip Strength (GRS)
Time frame: 3-month after intervention
active range of motion (AROM) of fingers
range of motion is a measurement to identify how far the person's joints range can move in flexion/extension
Time frame: 3-month after intervention
5Q-5D-5L questionnaire
It is a quality of life questionnaire
Time frame: 3-month after intervention
Start is estimated for Jan 2026; primary completion for Dec 2028, 35 months later.
Of 3,121 non-industry interventional studies with no phase under Stroke, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 46. This study's planned 35 months is above that.
Counting every sponsor, half of 3,265 studies reached it within 23 months; a quarter within 10 and three quarters within 46.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Chinese University of Hong Kong →